Login to Your Account


Stem cell-based model suggests deafness treatments

By John Fox
Staff Writer

Thursday, January 12, 2017

Researchers at Tokyo's Keio University School of Medicine have developed the first in vitro cochlear cell model using patient-derived disease-specific human induced pluripotent stem cells (hiPSCs), which allows study of the pathogenesis of congenital deafness and may lead to its treatment.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription